EGFR and ovarian carcinoma: Both ovarian carcinoma cell lines, SKOV-3 and SKOV3.ip1, showed biphasic binding of the pre-targeted liposomes indicating that pre-targeting results in liposome binding both in EGFR-specific and non-specific manner.